Literature DB >> 8058620

Dosing reproducibility from experimental albuterol suspension metered-dose inhalers.

P R Byron1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8058620     DOI： 10.1023/a:1018983019830

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  4 in total

1.  Influence of metering chamber volume and water level on the emitted dose of a suspension-based pMDI containing propellant 134a.

Authors:  R O Williams; J Liu; J J Koleng
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

2.  Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.

Authors:  Thomas E Tarara; Michael S Hartman; Howard Gill; Alan A Kennedy; Jeffry G Weers
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

3.  Influence of suspension stabilisers on the delivery of protein-loaded porous poly (DL-lactide-co-glycolide) (PLGA) microparticles via pressurised metered dose inhaler (pMDI).

Authors:  Elizabeth Cocks; Satyanarayana Somavarapu; Oya Alpar; David Greenleaf
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

4.  Loading effect on particle size measurements by inertial sampling of albuterol metered dose inhalers.

Authors:  M M Nasr; J F Allgire
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.